Leo Cancer Care - About the company
Leo Cancer Care is a series D company based in Crawley (United Kingdom), founded in 2014 by Thomas Rock Mackie and Paul Keall. It operates as a Manufacturer of upright patient positioning systems for radiation therapy treatments. Leo Cancer Care has raised $130M in funding from investors like Serra Ventures, Cone Health and Cosylab. The company has 14 active competitors, including 7 funded and 2 that have exited. Its top competitors include companies like Varian Medical Systems, Terapet and P-Cure.
Company Details
Manufacturer of upright patient positioning systems for radiation therapy treatments. These systems enable the delivery of radiation while patients remain in a seated or standing position. The equipment integrates with imaging technology to support simulation and treatment workflows. By utilizing upright positioning, the hardware facilitates compatibility with various radiation beam delivery systems. The design focuses on patient stability and comfort during the administration of therapeutic radiation.
- Website
- leocancercare.com
- Social
- Email ID
- *****@leocancercare.com
- Phone Number
- +44 **********
- Registered Address
- 151 THE GLADE,CROYDON,SURREY,CR0 7QR
Key Metrics
Founded Year
2014
Location
Crawley, United Kingdom
Stage
Series D
Total Funding
$130M in 4 rounds
Latest Funding Round
Investors
Ranked
2nd among 14 active competitors
Employee Count
131 as on Aug 31, 2026
Similar Companies
Legal entities associated with Leo Cancer Care
Leo Cancer Care is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CANCER CARE LTD CIN: 7294688 , United Kingdom, Active | Jun 23, 2010 | - | 1 (As on Jun 30, 2024) | |
LEO CANCER CARE LTD CIN: 11724218 , United Kingdom, Active | Dec 11, 2018 | - | 52 (As on Dec 31, 2024) |
Sign up to download Leo Cancer Care's company profile
Leo Cancer Care's funding and investors
Leo Cancer Care has raised a total funding of $130M over 4 rounds. Its first funding round was on Jul 20, 2021. Its latest funding round was a Series D round on Jul 08, 2026 for $*****. 2 investors participated in its latest round. Leo Cancer Care has 15 institutional investors.
Here is the list of recent funding rounds of Leo Cancer Care:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 08, 2026 | 6798052 | Series D | 2221020 | 2122922 | 6055776 | 1304880 |
Sep 24, 2025 | 9552936 | Series D | 3778775 | 9189532 | 5856370 | 3452933 |
Jun 11, 2024 | 6250420 | Series C | 7276721 | 9737171 | 4940109 |
Access funding benchmarks and valuations. Sign up today!View details of Leo Cancer Care's funding rounds and investors
Leo Cancer Care's founders and board of directors
Founder? Claim ProfileThe founders of Leo Cancer Care are Thomas Rock Mackie and Paul Keall. Stephen Towe is the CEO of Leo Cancer Care.
Here are the details of Leo Cancer Care's key team members:
- Thomas Rock Mackie: Co-Founder & Chairman of Leo Cancer Care. Contact Info: 1 email address
- Paul Keall: Co-Founder of Leo Cancer Care. Contact Info: 1 email address
- Stephen Towe: CEO of Leo Cancer Care. They serve on the board of 1 company.Contact Info: 1 email address
Leo Cancer Care's Board of Directors
Leo Cancer Care's board has 2 active members. Andrew Harley and Stephen Towe are independent board members.Here is the list of Leo Cancer Care's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 5y 2m | |
xtgahtr | Independent board member | - | Current | 6y 1m |
View details of Leo Cancer Care's Founder profiles and Board Members
Leo Cancer Care's employee count trend
Leo Cancer Care has 131 employees as of Aug 26. Here is Leo Cancer Care's employee count trend over the years:
Uncover Leo Cancer Care's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Leo Cancer Care's Competitors and alternates
Top competitors of Leo Cancer Care include Varian Medical Systems, Terapet and P-Cure. Here is the list of Top 10 competitors of Leo Cancer Care, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Varian Medical Systems 1948, Palo Alto (United States), Acquired | Provider and manufacturer of radiotherapy software and hardware solutions for professionals | - | 61/100 | |
2nd |  Leo Cancer Care 2014, Crawley (United Kingdom), Series D | Manufacturer of upright patient positioning systems for radiation therapy treatments | $130M | 59/100 | |
3rd |  Terapet 2019, Geneva (Switzerland), Seed | Developer of integrated imaging solutions for proton therapy and nuclear medicine | $3.75M | 51/100 | |
4th | Imaging-based proton radiation therapy for cancer treatment | $30M | - | 51/100 | |
5th |  Advanced Oncotherapy 1994, London (United Kingdom), Public | Provider of proton beam therapy system for the treatment of cancer | - | 43/100 | |
6th | HIL Medical 2010, Jerusalem (Israel), Series C | Developer of proton-beam radiotherapy device to treat solid tumors | $3.15M | 38/100 | |
7th | Provision Healthcare 2005, Knoxville (United States), Series B | Innovating cancer care with advanced proton therapy solutions and patient-centric approach | $30.4M | - | 38/100 |
8th |  B dot Medical 2017, Edogawa City (Japan), Series B | Developer of proton beam therapeutic devices for the treatment of cancer | $22M | 35/100 | |
9th |  Shanghai Aipqiang Particle Equipment 2012, Shanghai (China), Series A | Provider of proton therapy systems and related particle equipment | $6.29M | 29/100 | |
10th |  Proton Therapy Partners 2018, Wayne (United States), Funding Raised | Developer of proton therapy for treating cancer | - | 26/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Leo Cancer Care's competitors? Click here to see the top ones
Leo Cancer Care's Investments and acquisitions
Leo Cancer Care has made no investments or acquisitions yet.
Reports related to Leo Cancer Care
Here is the latest report on Leo Cancer Care's sector:
News related to Leo Cancer Care
Filter this listMedia has covered Leo Cancer Care for a total of 9 events in the last 1 year, 4 of them have been about company updates and 2 about partnerships.
•
•
•
•
•
Leo Cancer Care Secures CE Mark for Marie, Advancing Upright Radiotherapy in EuropeWebDisclosure•May 20, 2026•Leo Cancer Care
•
•
•
•
Leo Cancer Care Raises $40M to Commercialize Upright Radiotherapy SystemHIT Consultant•Sep 24, 2025•Catalio Capital Management, Leo Cancer Care
•
Leo Cancer Care Receives FDA Clearance for Marie® Upright Radiotherapy PlatformPR Newswire•Jul 29, 2025•Leo Cancer Care
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Leo Cancer Care
Explore our recently published companies
- Salmonandsable - Unfunded company
- Order Asprigofthymesrq - Unfunded company
- Pizzatupwalthamabbey - United Kingdom based, Unfunded company
- Damascusbakeryandsweets - United Kingdom based, Unfunded company
- Alifishandchips - United Kingdom based, Unfunded company
- Pasam Pizza Kebab - Germany based, Unfunded company
